Clinical Trial Update: Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids [Phase 2]

View source ↗

Summary

Phase 2 trial investigating tralokinumab for asthma inadequately controlled on corticosteroids has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08